--Must See--

Bioinformatics Summer Internship 2024 With Hands-On-Training + Project / Dissertation - 30 Days, 3 Months & 6 Months Duration

Anti-HIV Enzyme : German Scientists plan to ‘slice off’ HIV using novel Enzyme

A team of German researchers is working on a way to cut viral DNA out of a cell using an enzyme which could ultimately be used in cure of HIV. A combination of drugs is currently used to make up anti-retroviral therapy that helps in treatment of HIV. The anti-retroviral therapy treatment continued for many years is expensive. It also increases drug resistance and could cause adverse reactions in a patient.

The new enzyme will completely cut the HIV virus from a patient’s body.

And, because the virus stays in reservoirs in the body, the disease  can continue to progress in patients if they stop taking their  medication. According to the Richard Dawkins Foundation website the German team of researchers has found an enzyme that can ‘cut’ the viral DNA out of a cell’s genetic code which could eradicate the virus   from a patient’s body altogether.

The proof-of-concept study,  published this week in Nature Biotechnology and reported by Ars  Technica, was done in mice but the researchers believe that their conclusions show that this DNA-snipping enzyme could be used in  clinical practice.

If it can cut HIV’s genetic code out of a patient’s body, the  technique could be a cure for the disease. The researchers created the DNA-snipping enzyme called Brec1 using  directed evolution, an engineering technique that mimics proteins natural evolution process.

They programmed the enzyme to cut DNA on   either side of a sequence characteristic of HIV, a difficult task  since the DNA of organisms and of the virus itself mutates often. Still, the researchers identified a well-conserved sequence, then they   tested how reliably the enzyme could snip out that sequence in cells   taken from HIV-positive patients, in bacteria, and in mice infected with the human form of HIV.

After a number of tweaks, Brec1 would cut only that sequence of DNA, patching up the cell’s genetic code once the HIV sequence was cleaved out. After 21 weeks, the cells treated with Brec1 showed no signs of HIV.

Mandakini is a bioscience enthusiast and loves to portray a picture of “Science” like never before. Serving as an Editor in Biotecnika she has penned down many interesting news and articles in the past and has also helped in posting just the right job for you. Follow her for more updates in the industry !!